PHS
PRTA icon

PFM Health Sciences’s Prothena Corp PRTA Stock Holding History

PFM Health Sciences’s Portfolio PRTA Stock Details PRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-152,300
Closed -$9.18M – 98
2022
Q4 		$9.18M Buy
152,300
+71,800
+89% +$4.2M 0.33% 70
2022
Q3 		$4.88M Buy
+80,500
New +$2.54M 0.18% 73

Other funds holding PRTA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

PFM Health Sciences's PRTA Position: Q1 2024 in Review

PFM Health Sciences sold out of Prothena Corp (PRTA) in Q1 2024, closing a stake of 189,744 shares — an estimated $6.9M sold.

PFM Health Sciences first reported a position in PRTA in Q1 2014 and held it in 8 quarters. The position peaked at $52.9M in Q2 2023. 169 funds tracked by Wall St. Rank hold PRTA as of Q1 2024.

  • PFM Health Sciences reported no remaining Prothena Corp position as of Q1 2024 after selling out during the quarter.
  • PFM Health Sciences sold 189,744 Prothena Corp shares in Q1 2024, an estimated $6.9M.
  • PFM Health Sciences first reported a position in Prothena Corp in Q1 2014 and held it in 8 quarters.
  • PFM Health Sciences's Prothena Corp position peaked at $52.9M in Q2 2023.
  • 169 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2024.

Based on PFM Health Sciences's 13F filing for Q1 2024, filed 14 May 2024.